PIN1 degrader-3
PIN1 degrader-3 is a Pin1 (peptidyl-prolyl isomerase protein) (IC50=4.65 nM) molecular glue degrader. PIN1 degrader-3 bound covalently to Pin1. PIN1 degrader-3-induced Pin1 degradation reduced cell viability. PIN1 degrader-3 can destabilize Pin1 in vitro, causing its degradation in cells. PIN1 degrader-3 can be used for the study of pancreatic cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 3101950-55-1
- Formule: C31H34Cl2N6O4
- Masse moléculaire:625.55
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
IC50 & Target
|
Pin1 4.65 nM (IC50) |
In Vitro
PIN1 degrader-3 (Compound 164B8) (250 μM, 3 h) binds to Pin1, causing a conformational change that affects the loop FG and helix D regions[1].
PIN1 degrader-3 (0-15 μM, 24 h) effectively induces dose-dependent degradation of MIA PaCa-2 and Pin1 in human pancreatic cancer cell line BxPC3 and mouse pancreatic cancer cell line KPC[1].
PIN1 degrader-3 (5 μM, 24 h) induces Pin1 degradation in BxPC3 and KPC cell lines[1].
PIN1 degrader-3 (0.5-10 μM, 24 h) induces dose-dependent degradation of Pin1 in all CAFs (Cancer-Associated Fibroblasts) (CAF-BTG for cholangiocarcinoma, CAF-APP for appendiceal cancer, and CAF-COL for colorectal cancer)[1].
PIN1 degrader-3 induces Pin1 degradation and reduces cell viability, with EC50 values of 8.4 μM in MIA PaCa-2 cells and 5.3 μM in KPC cell lines[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:BxPC3 cells, MIA PaCa-2 cells, KPC cells
-
Concentration:0 μM, 0.5 μM, 1 μM, 3 μM, 5 μM, 10 μM, 15 μM
-
Incubation Time:24 h
-
Result:Pin1 protein levels decreased in a dose-dependent manner in all three cell lines.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male NSG mice were used to establish a peritoneal metastasis model by intraperitoneal injection of KPC pancreatic cancer cells expressing GFP and luciferase[1].
-
Dosage:30 mg/kg, 60 mg/kg
-
Administration:I.p., once a day, 5 days a week, for 2 weeks
-
Result:Tumor burden decreased significantly in a dose-dependent manner.
Mild anemia and moderate thrombocytopenia occurred in the 60 mg/kg group.
Chemical Information
-
CAS No. 3101950-55-1
-
Masse moléculaire 625.55
-
Formule C31H34Cl2N6O4
-
SMILES
O=C(NC)[C@@H](NC([C@@H]1CCCCN1C([C@@H](NC(CCl)=O)CC2=CNC3=C2C=CC(Cl)=C3)=O)=O)CC4=CNC5=C4C=CC=C5
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
CCK-8/WST-8 Cell Proliferation Assay
The CCK-8/WST-8 assay is based on the reduction of the water-soluble tetrazolium salt WST-8 to a water-soluble formazan product by cellular dehydrogenases in metabolically active cells, where the generated formazan amount is proportional to the number of living cells and is quantified by measuring absorbance in the visible range, providing a colorimetric readout for cell viability and proliferation assessment. This class of tetrazolium-based assays improves upon earlier MTT-based systems by producing a water-soluble formazan, eliminating the need for organic solubilization steps and enabling direct spectrophotometric measurement in culture medium.
-
MTT Cell Proliferation Assay
The MTT assay is a colorimetric endpoint assay for estimating viable cell number, cell growth, cytotoxicity, or cell activation in cultured mammalian cells. Living cells reduce the yellow tetrazolium salt MTT into purple/blue formazan, while dead cells do not generate the same signal; the resulting color can be quantified with a multiwell spectrophotometer. MTT reduction is commonly interpreted as a readout of metabolic activity that often correlates with viable cell number, but it should not be treated as a direct cell-counting method unless the assay is optimized for the cell type and experimental condition. Studies show that MTT reduction can involve mitochondrial and non-mitochondrial reducing systems, and formazan may accumulate in intracellular lipid droplets rather than simply marking mitochondria.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)